Prosecution Insights
Last updated: August 18, 2026

Examiner: ALVARADO JR, NELSON LOUIS

Tech Center 3700 • Art Units: 3783

This examiner grants 87% of resolved cases

Performance Statistics

86.7%
Allow Rate
+16.7% vs TC avg
88
Total Applications
+18.2%
Interview Lift
1160
Avg Prosecution Days
Based on 60 resolved cases, 2023–2026

Rejection Statute Breakdown

1.2%
§101 Eligibility
22.3%
§102 Novelty
48.3%
§103 Obviousness
21.4%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18119681 DEVICES, SYSTEMS, AND METHODS FOR CATHETER WITH ACTUATING PORTION Non-Final OA Boston Scientific Medical Device Limited
18105743 Skin Nicking Device for Catheter Placement System Final Rejection Bard Access Systems, Inc.
18105357 Skin Nicking Device for Catheter Placement System Non-Final OA Bard Access Systems, Inc.
18377972 ECHOGENIC BALLOON DILATION CATHETER AND BALLOON THEREOF Non-Final OA BECTON, DICKINSON AND COMPANY
17992438 Syringe Needle Shield with Integrated Disinfectant Non-Final OA Becton, Dickinson and Company
17852538 Vascular Access Device to Dispense Blood for Point-Of-Care Testing Non-Final OA Becton, Dickinson and Company
17852489 Vascular Access System Having a Dynamically Expandable Probe Non-Final OA Becton, Dickinson and Company
17946090 MEDICAL PUNCTURE NEEDLE Non-Final OA TERUMO KABUSHIKI KAISHA
17569291 SAFETY DEVICE FOR A PRE-FILLED SYRINGE AND AN INJECTION DEVICE Final Rejection Sanofi-Aventis Deutschland GMBH
17775651 CONTAINER HOLDER ASSEMBLY FOR MEDICAMENT DELIVERY DEVICE, AND MEDICAMENT DELIVERY DEVICE Final Rejection SHL MEDICAL AG
17906420 Multi-Component Sealant Delivery Systems Incorporating Quarter Turn Connectors Final Rejection BARD PERIPHERAL VASCULAR, INC.

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month